Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Dow
Colorcon
Mallinckrodt
Baxter

Last Updated: May 28, 2022

NOCTIVA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

When do Noctiva patents expire, and when can generic versions of Noctiva launch?

Noctiva is a drug marketed by Serenity Pharms Llc and is included in one NDA. There are four patents protecting this drug.

This drug has one hundred and eight patent family members in thirty-one countries.

The generic ingredient in NOCTIVA is desmopressin acetate. There are twenty drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the desmopressin acetate profile page.

US Patents and Regulatory Information for NOCTIVA

NOCTIVA is protected by four US patents.

Patents protecting NOCTIVA

Pharmaceutical compositions including low dosages of desmopressin
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: A METHOD OF TREATING NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS

Pharmaceutical compositions including low dosages of desmopressin
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: A METHOD OF TREATING NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS

Pharmaceutical compositions including low dosages of desmopressin
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Safe desmopressin administration
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Serenity Pharms Llc NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-001 Mar 3, 2017 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Serenity Pharms Llc NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-002 Mar 3, 2017 DISCN Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Serenity Pharms Llc NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-001 Mar 3, 2017 DISCN Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Serenity Pharms Llc NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-001 Mar 3, 2017 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Serenity Pharms Llc NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-001 Mar 3, 2017 DISCN Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Serenity Pharms Llc NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-002 Mar 3, 2017 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Serenity Pharms Llc NOCTIVA desmopressin acetate SPRAY, METERED;NASAL 201656-002 Mar 3, 2017 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for NOCTIVA

See the table below for patents covering NOCTIVA around the world.

Country Patent Number Title Estimated Expiration
Denmark 2381923 See Plans and Pricing
South Korea 20170081711 비내 데스모프레신 투여를 위한 장치 (A DEVICE FOR INTRANASAL DESMOPRESSIN ADMINISTRATION) See Plans and Pricing
Israel 213699 מכשיר למתן תוך-אפי של דזמופרסין (Intranasal desmopressin dispenser) See Plans and Pricing
South Korea 102059255 See Plans and Pricing
Canada 2484724 PREPARATIONS PHARMACEUTIQUES (DESMOPRESSIN IN AN ORODISPERSIBLE DOSAGE FORM) See Plans and Pricing
China 1981745 Pharmaceutical formulations See Plans and Pricing
Uruguay 27683 FORMULACIONES FARMACÉUTICAS See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for NOCTIVA

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2712622 C02712622/01 Switzerland See Plans and Pricing PRODUCT NAME: DESMOPRESSIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66379 16.03.2018
2712622 LUC00015 Luxembourg See Plans and Pricing PRODUCT NAME: DESMOPRESSINE OU UN DE SES SELS D'ACETATE; AUTHORISATION NUMBER AND DATE: 497271; 497280 20161101
3225249 CA 2019 00023 Denmark See Plans and Pricing PRODUCT NAME: DESMOPRESSIN ELLER ET ACETATSALT DERAF; NAT. REG. NO/DATE: 55858, 55859 (DK) 20160526; FIRST REG. NO/DATE: BE BE497271, BE497280 20160504
3225249 300983 Netherlands See Plans and Pricing PRODUCT NAME: DESMOPRESSIN, DESGEWENST IN DE VORM VAN EEN ACETAAT ZOUT; REGISTRATION NO/DATE: BE497271 & BE497280 20160513
2712622 122017000006 Germany See Plans and Pricing PRODUCT NAME: DESMOPRESSIN ODER DAS ACETAT DAVON; NAT. REGISTRATION NO/DATE: 94725.00.00 94726.00.00 20160901 FIRST REGISTRATION: BELGIEN BE497271 BE497280 20160504
3225249 2019C/520 Belgium See Plans and Pricing PRODUCT NAME: DESMOPRESSINE OF EEN ACETAATZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: BE497271 - BE497280 20160513
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Dow
Boehringer Ingelheim
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.